Basic Materials / Specialty ChemicalsAthens
$10.25
-0.30 (-2.84%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $9.6M · quality 73.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
62/100
B
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$154M
P/E
15.5x
↓EV/EBITDA
9.9x
↓ROE
13.1%
↑Gross Margin
33.4%
↑Debt/Equity
0.71
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+3.1%
FCF CAGR
+9.6%
FCF margin
15.1%
FCF / Net income
0.97x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $63.4M · net income $9.9M · FCF $9.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $63.4M | $63.4M | $58.1M | $53.7M | $57.7M |
| Net Income | $9.9M | $9.9M | $7.4M | $5.2M | $6.2M |
| EBITDA | $19.7M | $19.7M | $17.5M | $15.0M | $14.8M |
| EPS | 0.66 | 0.66 | 0.50 | 0.35 | 0.41 |
| Gross Margin | 33.4% | 33.4% | 33.3% | 30.0% | 27.6% |
| Operating Margin | 22.9% | 22.9% | 22.0% | 19.4% | 17.8% |
| Net Margin | 15.6% | 15.6% | 12.8% | 9.7% | 10.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.71 | 0.71 | 0.79 | 1.05 | 1.35 |
| Cash Flow | |||||
| Free Cash Flow | $9.6M | $9.6M | $9.0M | $10.9M | $7.3M |
| Returns | |||||
| ROE | 13.1% | 13.1% | 11.3% | 8.9% | 11.7% |
| Valuation | |||||
| P/E | 15.53 | 15.53 | 6.89 | 9.76 | 7.23 |
| EV/EBITDA | 9.86 | 9.86 | 5.79 | 7.34 | 7.77 |
| P/B | 2.03 | 2.03 | 0.78 | 0.87 | 0.85 |
| Growth & Yield | |||||
| Revenue Growth | 9.1% | 9.1% | 8.2% | -7.1% | — |
| EPS Growth | 32.8% | 32.8% | 42.5% | -16.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
11.3%
EPS terminal req.
$0.91
Spread vs growth
21.4%
5Y implied EPS CAGR
10.8%
EPS terminal req.
$1.10
Spread vs growth
22.0%
10Y implied EPS CAGR
10.4%
EPS terminal req.
$1.77
Spread vs growth
22.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+156.3%
Start / end P/E
8.1x → 15.6x
EPS bridge
0.50 → 0.66
Residual
+30.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.